Inventor · disambiguated record
Vladimir Coric
Also filed as: CORIC VLADIMIR
16 granted patents·30 pending applications·26 citations·filing 2006–2025
90Inventor score
Files withBIOHAVEN THERAPEUTICS LTD11BIOHAVEN PHARM HOLDING CO LTD10BRISTOL MYERS SQUIBB CO9UNIV YALE6BIOHAVEN PHARMACEUTICAL IRELAND DAC3
Top patents by PatentIndex Score
46 records- 0194US10668152B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 2, 2020·7 cites·21 claims
- 0293US10392442B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 27, 2019·6 cites·20 claims
- 0392US11083724B2Rimegepant for CGRP related disordersBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Aug 10, 2021·4 cites·20 claims
- 0487US11965031B2Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 23, 2024·1 cites·18 claims
- 0587US11400155B2Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancersBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Aug 2, 2022·2 cites·19 claims
- 0687US2024360235A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0786US2025360208A1Use of glutamate modulating agents with immunotherapies to treat cancerBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0881US11660267B2Sublingual formulation of riluzoleBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD B·Filed 2015·Granted May 30, 2023·5 cites·13 claims
- 0978US2024238416A1Use of immune checkpoint inhibitors in central nervous systems neoplasmsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1078US2025114301A1Sublingual formulation of riluzoleBIOHAVEN THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1177US2023310595A1Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancersBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1276US8778979B2Glutamate agents in the treatment of mental disordersCORIC VLADIMIR·Filed 2006·Granted Jul 15, 2014·1 cites·6 claims
- 1376US2025154274A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1474US2021294011A1Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2021·Application pending·0 cites
- 1573US2021093629A1Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2020·Application pending·0 cites
- 1672US11554117B2Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2018·Granted Jan 17, 2023·0 cites·2 claims
- 1772US2021093630A1Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2020·Application pending·0 cites
- 1871US2020024355A1Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1967US12121609B2Sublingual formulation of riluzoleBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Oct 22, 2024·0 cites·14 claims
- 2067US12102618B2Use of riluzole prodrugs to treat ataxiasBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Oct 1, 2024·0 cites·13 claims
- 2167US2017360775A1Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2017·Application pending·0 cites
- 2265US10052318B2Glutamate agents in the treatment of mental disordersUNIV YALE·Filed 2014·Granted Aug 21, 2018·0 cites·6 claims
- 2364US12364687B2Use of riluzole oral disintegrating tablets for treating diseasesBIOHAVEN PHARM HOLDING CO LTD·Filed 2019·Granted Jul 22, 2025·0 cites·4 claims
- 2464US2021000953A1Use of immune checkpoint inhibitors in central nervous systems neoplasmsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2563US12383619B2Use of glutamate modulating agents with immunotherapies to treat cancerBIOHAVEN THERAPEUTICS LTD·Filed 2017·Granted Aug 12, 2025·0 cites·24 claims
- 2663US2022168295A1Rimegepant for cgrp related disordersBIOHAVEN PHARMACEUTICAL IRELAND DAC·Filed 2021·Application pending·0 cites
- 2760US2021000814A1Rimegepant for cgrp related disordersBIOHAVEN PHARM HOLDING CO LTD·Filed 2019·Application pending·0 cites
- 2858US2021196699A1Cgrp antagonists for treating migraine breakthroughBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2957US2024082340A1Use of riluzole prodrugs to treat alzheimer's diseaseBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 3056US12201618B2Use of riluzole prodrugs to treat Alzheimer's diseaseBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted Jan 21, 2025·0 cites·7 claims
- 3154US12161633B2Use of riluzole prodrugs to treat alzheimer's diseaseBIOHAVEN THERAPEUTICS LTD·Filed 2019·Granted Dec 10, 2024·0 cites·13 claims
- 3254US2023285380A1Dual treatment of migraineBIOHAVEN PHARMACEUTICAL IRELAND DAC·Filed 2022·Application pending·0 cites
- 3354US2021338654A1Cgrp antagonists for treating migraine breakthroughBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 3453US2023181541A1Compositions and methods for treating obsessive-compulsive disorderBIOHAVEN THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3553US2018133313A1Use of immune checkpoint inhibitors in central nervous systems neoplasmsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3653US2021315865A1Use of riluzole oral disintigrating tablets for treating diseasesBIOHAVEN THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3753US2024408080A1Pharmaceutical compositions of cgrp inhibitors and methods of their usePFIZER IRELAND PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 3851US7869010B2Method for evaluating purity and concentration of oils and fatty acid compositionsCENESTRA LLC·Filed 2009·Granted Jan 11, 2011·0 cites·8 claims
- 3951US2024366618A1CGRP Antagonists for Treating Trigeminal NeuralgiaPFIZER IRELAND PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 4051US2023285390A1Methods of treating pulmonary injury with cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 4150US2006167068A1Method of treating self-injurious behavior with glutamate modulating agentsFEUERSTEIN SETH·Filed 2006·Application pending·0 cites
- 4250US2022401439A1Intranasal pharmaceutical compositions of cgrp inhibitorsBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 4350US2023108049A1Oral fast-dispersing dosage form of rimegepantBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 4449US2023321066A1Preventative treatment of migraineBIOHAVEN PHARMACEUTICAL IRELAND DAC·Filed 2021·Application pending·0 cites
- 4541US2021023061A1Use of riluzole prodrugs to treat ataxiasBIOHAVEN PHARM HOLDING CO LTD·Filed 2018·Application pending·0 cites
- 4632US2018153862A1Sublingual administration of riluzoleBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD B·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vladimir Coric files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →